• Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Receives Consensus Rating of "Moderate Buy" from Brokerages

    Source: Buzz FX / 18 Mar 2025 01:16:16   America/Chicago


    Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Receives Consensus Rating of "Moderate Buy" from Brokerages Written by MarketBeat March 18, 2025 Share Link copied to clipboard. Remove Ads Iovance Biotherapeutics, Inc.
    Read more...
Share on,